Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
induced pluripotent stem cells (iPSCs); differentiation of pluripotent cells into neuronal lineages; genome engineering using CRISPR/Cas9; molecular biology and biochemistry laboratory techniques (e.g
-
-funded research projects, this position provides support in the operation of the research laboratory. The responsibilities will include preparation of human stem cell cultures from repository specimens
-
Jobs from This Employer https://main.hercjobs.org/jobs/21861431/postdoctoral-scholar-in-regenerative-therapy-and-stem-cell-biology-in-cornea-diseases Return to Search Results
-
Stem cell therapies offer a new therapeutic paradigm in regenerative medicine. Bioengineering approaches can help to deliver specialised cells targeting specific clinical challenges, yet there
-
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt | Stein bei N rnberg, Bayern | Germany | 4 days ago
applications, improving lives. Recently, our Gene Editing group at the Institute of Stem Cell Research developed Synthetic Transfer Vehicles (STVs), a programmable protein-based RNA delivery platform
-
Range: The per credit rate is $2,208 - $2,885 To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Part-Time-Lecturer--Stem-Cells---Regeneration--CGT-program
-
in Biomedicine & Health; Emerging Infectious Diseases; Global Health; Immunology and Virology; Neuroscience; Stem Cell & Regenerative Medicine; Nursing; Pharmacology & Pharmacy; and Structural
-
University of California, San Francisco | San Francisco, California | United States | about 3 hours ago
nearly every area of health. We are home to five Nobel laureates who have advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community
-
will be determined by the supervisor. What you'll do Cell culture and maintenance of pluripotent stem cells and differentiating inner ear and skin organoids under sterile conditions Immunohistochemistry
-
Leukemia DC15: Novel preclinically-validated GATA3 inhibitor/degrader as a therapy for T-cell Acute Lymphoblastic Leukemia DC16: Targeting Metabolic Pathways in Leukemic Stem Cells for AML Treatment